Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) on the 14th of December 2021

14/12/2021

At the extraordinary General Meeting in Magle Chemoswed Holding AB, held on December 14th, 2021, by way of postal voting procedure the main resolutions passed were the following:

  • EGM resolved that the Board of Directors continue to consist of six (6) members and one (1) deputy member;
  • Martin Lidgard was elected as new member of the Board until the end of general meeting 2022;
  • EGM resolved that remuneration to the Board of Directors decided at the annual general meeting 2021 shall be applied and distributed pro rata to the new member- Martin Lidgard.

Minutes from the Extraordinary General Meeting with complete resolutions will be made available at https://maglegroup.com/

Contacts

Justin Pierce, CEO, phone +46 (0)70 593 58 21, justin.pierce@maglechemoswed.com

About Us

Magle Chemoswed is a unique international contract development manufacturing company dedicated to bringing ideas to product for customers alongside building our own product pipeline based on our patented technology base. As an integrated company, we have extensive capabilities across the value chain, from the discovery, development and manufacture of medicines and medical devices that rely on our patented and trade secret protected technology platform. Learn more on www.maglechemoswed.com and https://maglegroup.com/

Västra Hamnen Corporate Finance is the Company's certified advisor on Nasdaq First North Growth Market and can be reached at ca@vhcorp.se or +46 (0) 40 200 250.

Attachments

Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) on the 14th of December 2021